PMID: 22587513May 17, 2012Paper

FGF21: The center of a transcriptional nexus in metabolic regulation

Current Diabetes Reviews
A C Adams, Alexei Kharitonenkov

Abstract

Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity. Recent publications have demonstrated that FGF21 resides downstream of a complex network of transcriptional regulators which modulate its expression in response to a wide array of physiological stimuli or pharmacologic agents. The manner in which these mechanisms are integrated to regulate FGF21 transcription, production and subsequent secretion is poorly understood. While FGF21 is detected in many metabolically active tissues and is regulated by several of the known transcription factors involved in metabolic control little is known about how these pathways are integrated. In this review, we discuss the data presented to date on regulation of FGF21 by a wide array of transcription factors and explore how it relates to metabolic regulation in vivo.

Citations

Aug 6, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P LeeF S Celi
Apr 29, 2014·Toxicology and Applied Pharmacology·Xingguo ChengCurtis D Klaassen
Feb 1, 2013·Current Diabetes Reviews·Dionysios V Chartoumpekis, Thomas W Kensler
Jan 1, 2015·Scandinavian Journal of Clinical and Laboratory Investigation·Zhan-Chun LiJi-Dong Zhang
Sep 19, 2014·Annals of Medicine·Rubén CereijoFrancesc Villarroya
Apr 20, 2013·Trends in Endocrinology and Metabolism : TEM·Gaëlle FilhoulaudCatherine Postic
Jul 23, 2015·Kidney International·Helen C LookerUNKNOWN SUMMIT Investigators
Mar 31, 2015·Cell·Laurent GautronKevin W Williams
Sep 4, 2015·Scientific Reports·Aleix Gavaldà-NavarroFrancesc Villarroya
Apr 1, 2015·Journal of Cellular and Molecular Medicine·Xiaoqing YanYi Tan
Sep 18, 2013·Biochemical and Biophysical Research Communications·Kook Hwan KimMyung-Shik Lee
May 18, 2016·International Journal of Endocrinology·Yueye HuangShen Qu
Mar 23, 2015·Diabetes Research and Clinical Practice·Jian-Jun LiuSu Chi Lim
May 10, 2015·Cell Reports·Ricardo J SammsAndrew C Adams
May 2, 2015·Biochemical and Biophysical Research Communications·Wudelehu WuKatsumi Iizuka
Sep 21, 2013·Molecular Metabolism·Andrew C AdamsAlexei Kharitonenkov
May 15, 2013·Cell Metabolism·William L HollandPhilipp E Scherer
Jun 10, 2014·Hormones and Behavior·Ricardo J SammsFrancis J P Ebling
Sep 23, 2016·Molecular Metabolism·Garima SinghalEleftheria Maratos-Flier
Jun 9, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·H Frikke-SchmidtR J Seeley
Jul 26, 2016·Frontiers in Endocrinology·Patrick Joseph AntonellisAndrew Charles Adams
Oct 1, 2016·Molecular Metabolism·Miguel Angel Sánchez-GarridoAlexei Kharitonenkov
Oct 23, 2015·Trends in Endocrinology and Metabolism : TEM·Alexei Kharitonenkov, Richard DiMarchi
Feb 9, 2018·The Journal of Physiological Sciences : JPS·Umit YilmazSuleyman Sandal
Feb 20, 2015·Endocrine Reviews·Yuechi Xu, Zhongjie Sun
Sep 25, 2017·Endocrine Reviews·Harald StaigerHans-Ulrich Häring
Apr 5, 2014·Expert Review of Cardiovascular Therapy·Bernard M Y Cheung, H B Deng
Oct 22, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Masato MiyakeSeiichi Oyadomari
Feb 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fanghua LiZheng Dong
Jun 27, 2020·Cancers·Aishani SachdevaIrene Chong
Nov 24, 2016·Journal of Internal Medicine·A Kharitonenkov, R DiMarchi
Jun 28, 2017·Scientific Reports·Jo E LewisFrancis J P Ebling

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Richard SmithYang Li
The Journal of Clinical Investigation
Alexei KharitonenkovArmen B Shanafelt
© 2021 Meta ULC. All rights reserved